Dr. Aik Goh joined Reistone in 2018 as the Chief Medical Officer. He has 18 years of experiences in clinical and pharmaceutical industry. Dr. Goh is also a UK General Medical Council (GMC) registered doctor.
Prior to joining Reistone, Dr. Goh worked in GSK for 10 years, taking on increasingly important roles in mid and late phase clinical development. He was first based in the London head office and subsequently moved to China 5 years ago. He has significant experience in global and China registration programs leading to NDA approvals. While in China, he led multiple medical function teams, including clinical research, medical affair and MSLs in Respiratory and Neuroscience TA.
Dr. Goh received his Bachelor of Medicine and Surgery degree from the University of Aberdeen, UK, and has subsequently received a Doctorate of Medicine degree from Aberdeen. His MD research focused on the association between gastrointestinal reflux disease and the etiology of esophageal adenocarcinoma. Dr. Goh is also a Member of the Royal College of Surgeons of Edinburgh and the Royal College of Surgeons and Physicians of Glasgow.